Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis
Article in Neurology (March 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
Article in Neurology and Therapy (April 2023)
Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort study
Preprint in medRxiv (October 2022)